Inactivated Hantaan virus vaccine derived from suspension culture of Vero cells

Y. Choi, C. J. Ahn, K. M. Seong, M. Y. Jung, Byung-Yoon Ahn

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

We have developed a cell culture-derived, inactivated vaccine against Hantaan virus for prevention of the hemorrhagic fever with renal syndrome (HFRS). Hantaan virus was purified from a microcarrier culture of Vero E6 cells by ultrafiltration and density gradient centrifugation. Viral infection was inactivated by treatment of the viral stock with formaldehyde. Immunogenic properties of the vaccine were characterized in comparison with Hantavax, a mouse brain-derived, formalin-inactivated vaccine that has been in human use for a decade in Korea. Compared to the Hantavax, immunization of Balb/c mice with the cell culture-based vaccine resulted in a moderate difference in antibody response to the viral nucleocapsid protein but more than five-fold increase in neutralizing activity. Moreover, all six mice immunized with 5μg of the cell culture-based vaccine were fully protected from challenge with infectious virus, whereas virus was detected in lung and spleen of all animals immunized with the same dose of Hantavax. Four times higher dose of the latter vaccine was needed for complete protection. In the analysis of the humoral immune response to the vaccines, we found that all three viral structural proteins, N, G1 and G2 were immunoprecipitated by sera from animals immunized with the cell culture-based vaccine. In contrast, N and some G1 but no G2 were precipitated by the sera from animals immunized with Hantavax. These results suggest that the cell culture-based vaccine can provide more effective immunity than the Hantavax.

Original languageEnglish
Pages (from-to)1867-1873
Number of pages7
JournalVaccine
Volume21
Issue number17-18
DOIs
Publication statusPublished - 2003 May 16

Fingerprint

Hantaan virus
Vero Cells
Suspensions
Vaccines
vaccines
cell culture
Cell Culture Techniques
cells
Inactivated Vaccines
inactivated vaccines
viral proteins
Formaldehyde
mice
nucleocapsid proteins
Hemorrhagic Fever with Renal Syndrome
Viruses
Viral Structural Proteins
Nucleocapsid Proteins
viruses
animals

Keywords

  • Cell culture-based inactivated vaccine
  • Hantaan virus
  • HFRS
  • Vero E6 cell

ASJC Scopus subject areas

  • Immunology
  • Microbiology
  • Virology
  • Infectious Diseases
  • Public Health, Environmental and Occupational Health
  • veterinary(all)

Cite this

Inactivated Hantaan virus vaccine derived from suspension culture of Vero cells. / Choi, Y.; Ahn, C. J.; Seong, K. M.; Jung, M. Y.; Ahn, Byung-Yoon.

In: Vaccine, Vol. 21, No. 17-18, 16.05.2003, p. 1867-1873.

Research output: Contribution to journalArticle

Choi, Y. ; Ahn, C. J. ; Seong, K. M. ; Jung, M. Y. ; Ahn, Byung-Yoon. / Inactivated Hantaan virus vaccine derived from suspension culture of Vero cells. In: Vaccine. 2003 ; Vol. 21, No. 17-18. pp. 1867-1873.
@article{9803b10a5ede4b64922860de1231a19f,
title = "Inactivated Hantaan virus vaccine derived from suspension culture of Vero cells",
abstract = "We have developed a cell culture-derived, inactivated vaccine against Hantaan virus for prevention of the hemorrhagic fever with renal syndrome (HFRS). Hantaan virus was purified from a microcarrier culture of Vero E6 cells by ultrafiltration and density gradient centrifugation. Viral infection was inactivated by treatment of the viral stock with formaldehyde. Immunogenic properties of the vaccine were characterized in comparison with Hantavax, a mouse brain-derived, formalin-inactivated vaccine that has been in human use for a decade in Korea. Compared to the Hantavax, immunization of Balb/c mice with the cell culture-based vaccine resulted in a moderate difference in antibody response to the viral nucleocapsid protein but more than five-fold increase in neutralizing activity. Moreover, all six mice immunized with 5μg of the cell culture-based vaccine were fully protected from challenge with infectious virus, whereas virus was detected in lung and spleen of all animals immunized with the same dose of Hantavax. Four times higher dose of the latter vaccine was needed for complete protection. In the analysis of the humoral immune response to the vaccines, we found that all three viral structural proteins, N, G1 and G2 were immunoprecipitated by sera from animals immunized with the cell culture-based vaccine. In contrast, N and some G1 but no G2 were precipitated by the sera from animals immunized with Hantavax. These results suggest that the cell culture-based vaccine can provide more effective immunity than the Hantavax.",
keywords = "Cell culture-based inactivated vaccine, Hantaan virus, HFRS, Vero E6 cell",
author = "Y. Choi and Ahn, {C. J.} and Seong, {K. M.} and Jung, {M. Y.} and Byung-Yoon Ahn",
year = "2003",
month = "5",
day = "16",
doi = "10.1016/S0264-410X(03)00005-7",
language = "English",
volume = "21",
pages = "1867--1873",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "17-18",

}

TY - JOUR

T1 - Inactivated Hantaan virus vaccine derived from suspension culture of Vero cells

AU - Choi, Y.

AU - Ahn, C. J.

AU - Seong, K. M.

AU - Jung, M. Y.

AU - Ahn, Byung-Yoon

PY - 2003/5/16

Y1 - 2003/5/16

N2 - We have developed a cell culture-derived, inactivated vaccine against Hantaan virus for prevention of the hemorrhagic fever with renal syndrome (HFRS). Hantaan virus was purified from a microcarrier culture of Vero E6 cells by ultrafiltration and density gradient centrifugation. Viral infection was inactivated by treatment of the viral stock with formaldehyde. Immunogenic properties of the vaccine were characterized in comparison with Hantavax, a mouse brain-derived, formalin-inactivated vaccine that has been in human use for a decade in Korea. Compared to the Hantavax, immunization of Balb/c mice with the cell culture-based vaccine resulted in a moderate difference in antibody response to the viral nucleocapsid protein but more than five-fold increase in neutralizing activity. Moreover, all six mice immunized with 5μg of the cell culture-based vaccine were fully protected from challenge with infectious virus, whereas virus was detected in lung and spleen of all animals immunized with the same dose of Hantavax. Four times higher dose of the latter vaccine was needed for complete protection. In the analysis of the humoral immune response to the vaccines, we found that all three viral structural proteins, N, G1 and G2 were immunoprecipitated by sera from animals immunized with the cell culture-based vaccine. In contrast, N and some G1 but no G2 were precipitated by the sera from animals immunized with Hantavax. These results suggest that the cell culture-based vaccine can provide more effective immunity than the Hantavax.

AB - We have developed a cell culture-derived, inactivated vaccine against Hantaan virus for prevention of the hemorrhagic fever with renal syndrome (HFRS). Hantaan virus was purified from a microcarrier culture of Vero E6 cells by ultrafiltration and density gradient centrifugation. Viral infection was inactivated by treatment of the viral stock with formaldehyde. Immunogenic properties of the vaccine were characterized in comparison with Hantavax, a mouse brain-derived, formalin-inactivated vaccine that has been in human use for a decade in Korea. Compared to the Hantavax, immunization of Balb/c mice with the cell culture-based vaccine resulted in a moderate difference in antibody response to the viral nucleocapsid protein but more than five-fold increase in neutralizing activity. Moreover, all six mice immunized with 5μg of the cell culture-based vaccine were fully protected from challenge with infectious virus, whereas virus was detected in lung and spleen of all animals immunized with the same dose of Hantavax. Four times higher dose of the latter vaccine was needed for complete protection. In the analysis of the humoral immune response to the vaccines, we found that all three viral structural proteins, N, G1 and G2 were immunoprecipitated by sera from animals immunized with the cell culture-based vaccine. In contrast, N and some G1 but no G2 were precipitated by the sera from animals immunized with Hantavax. These results suggest that the cell culture-based vaccine can provide more effective immunity than the Hantavax.

KW - Cell culture-based inactivated vaccine

KW - Hantaan virus

KW - HFRS

KW - Vero E6 cell

UR - http://www.scopus.com/inward/record.url?scp=0037449056&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037449056&partnerID=8YFLogxK

U2 - 10.1016/S0264-410X(03)00005-7

DO - 10.1016/S0264-410X(03)00005-7

M3 - Article

C2 - 12706671

AN - SCOPUS:0037449056

VL - 21

SP - 1867

EP - 1873

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 17-18

ER -